Combined effect of rifampicin-induced P-glycoprotein expression and lipopolysaccharide-induced intestinal sepsis on the effective permeability and pharmacokinetics of an anti-malarial candidate CDRI 97/78 in rats

References

• Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. (2005). Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx 2:554–71
   PubMedGoogle Scholar
• Boobis A, Gundert-Remy U, Kremers P, et al. (2002). In silico prediction of ADME and pharmacokinetics: report of an expert meeting organised by COST B15. Eur J Pharm Sci 17:183–93
   PubMed Web of Science ®Google Scholar
• Chaumeil J. (1998). Micronization: a method of improving the bioavailability of poorly soluble drugs. Method Find Exp Clin Pharmacol 20:211–16
   PubMed Web of Science ®Google Scholar
• Clark IA, Alleva LM, Mills AC, Cowden WB. (2004). Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 17:509–39
   PubMed Web of Science ®Google Scholar
• Dawson DA, Wadsworth G, Palmer AM. (2001). A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke. Brain Res 892:344–50
   PubMed Web of Science ®Google Scholar
• Englund G, Rorsman F, Rönnblom A, et al. (2006). Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 29:269–77
   PubMed Web of Science ®Google Scholar
• Fagerholm U, Johansson M, Lennernäs H. (1996). Comparison between permeability coefficients in rat and human jejunum. Pharm Res 13:1336–42
   PubMed Web of Science ®Google Scholar
• Geick A, Eichelbaum M, Burk O. (2001). Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276:14581–7
   PubMed Web of Science ®Google Scholar
• Härtter S, Koenen-Bergmann M, Sharma A, et al. (2012). Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin. Br J Clin Pharmacol 74:490–500
   PubMed Web of Science ®Google Scholar
• Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. (1992). Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 52:453–7
   PubMed Web of Science ®Google Scholar
• Ince C. (2005). The microcirculation is the motor of sepsis. Crit Care 9:S13
   PubMed Web of Science ®Google Scholar
• Li M, Si L, Pan H, et al. (2011). Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm 403:37–45
   PubMed Web of Science ®Google Scholar
• Moore J, Morris D. (1992). Endotoxemia and septicemia in horses: experimental and clinical correlates. J Am Vet Med Assoc 200:1903–14
   PubMed Web of Science ®Google Scholar
• Munford RS, Hall CL. (1986). Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234:203–5
   PubMed Web of Science ®Google Scholar
• Nusrat A, Turner J, Madara J. (2000). IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279:G851–7
   PubMed Web of Science ®Google Scholar
• Opal SM, Scannon PJ, Vincent J-L, et al. (1999). Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584–9
   PubMed Web of Science ®Google Scholar
• Pombo DJ, Lawrence G, Hirunpetcharat C, et al. (2002). Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360:610–17
   PubMed Web of Science ®Google Scholar
• Rabba AK, Si L, Xue K, et al. (2011). In situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay. J Pharm Pharm Sci 14:138–47
   PubMed Web of Science ®Google Scholar
• Sandström R, Lennernäs H. (1999). Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats. Drug Metab Dispos 27:951–5
   PubMed Web of Science ®Google Scholar
• Shafiq N, Rajagopalan S, Kushwaha H, et al. (2014). Single ascending dose safety and pharmacokinetics of CDRI-97/78: first-in-human study of a novel antimalarial drug. Malar Res Treat 2014:372521
   Google Scholar
• Singh RP, Sabarinath S, Gautam N, et al. (2011). Pharmacokinetic study of the novel, synthetic trioxane antimalarial compound 97-78 in rats using an LC-MS/MS method for quantification. Arzneimittelforschung 61:120–5
   PubMed Web of Science ®Google Scholar
• Song N-N, Li Q-S, Liu C-X. (2006). Intestinal permeability of metformin using single-pass intestinal perfusion in rats. World J Gastroenterol 12:4064–70
   PubMed Web of Science ®Google Scholar
• Sousa M, Pozniak A, Boffito M. (2008). Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs. J Antimicrob Chemother 62:872–8
   PubMed Web of Science ®Google Scholar
• Svensson US, Sandström R, Carlborg Ö, et al. (1999). High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. Drug Metab Dispos 27:227–32
   PubMed Web of Science ®Google Scholar
• Thummel KE. (2007). Gut instincts: CYP3A4 and intestinal drug metabolism. J Clin Invest 117:3173–6
   PubMed Web of Science ®Google Scholar
• Varma MV, Obach RS, Rotter C, et al. (2010). Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem 53:1098–108
   PubMed Web of Science ®Google Scholar
• Zhou W, Di LQ, Shan JJ, et al. (2011). Intestinal absorption of forsythoside A in different compositions of Shuang-Huang-Lian. Fitoterapia 82:375–82
   PubMed Web of Science ®Google Scholar
• Zhou W, Di LQ, Wang J, et al. (2012). Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models. Acta Pharmacol Sinica 33:1069–79
   PubMed Web of Science ®Google Scholar